GLP-1 (S) + Cagrilintide – Research-Grade Dual Peptide Blend

This formulation consists of two structurally distinct, long-acting synthetic peptide analogs: a glucagon-like peptide-1 (GLP-1) receptor agonist analog and a modified amylin analog. Each peptide is independently synthesized and characterized, then combined in defined proportions to create a reproducible dual-peptide research system.

In laboratory research environments, this blend is utilized as a reference material for studying multi-receptor peptide interaction models, comparative signaling pathway analysis, and structure–function relationships associated with long-acting peptide analogs. The defined composition allows controlled investigation of peptide stability, receptor-binding dynamics, and combination peptide behavior under in vitro experimental conditions.

Unlike intact proteins or complex biologic mixtures, this formulation represents a precisely manufactured dual-peptide construct designed to support mechanistic assays and exploratory biochemical research. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.